Recent Posts
Categories
Tag Archives: trials
Italy’s high court says Berlusconi trials to stay in Milan
ROME (Reuters) – Italy’s top appeals court on Monday rejected a request by former prime minister Silvio Berlusconi to move two trials he faces out of Milan where, he has maintained, he cannot get a fair trial.
RPT-Slow approvals put India’s drug trials industry at risk
MUMBAI/NEW DELHI, Feb 13 (Reuters) – Slower government approval for testing new medicines is threatening India’s aspirations to be a fast-growing, low-cost hub for clinical trials, and has prompted some drugs firms to shift operations elsewhere, adding to their costs.
Fewer poor cancer patients referred for drug trials
NEW YORK (Reuters Health) – Among people with advanced cancer, poorer patients are less likely to be referred for clinical trials of experimental drugs, a new study from the UK suggests.
Cancer trials can lack clear information on biopsies
NEW YORK (Reuters Health) – People participating in cancer drug trials aren’t always given the most straightforward explanation of possible risks and benefits from invasive procedures that may be involved, according to a new study.
UPDATE 2-FDA lifts hold on trials of Insmed lung drug, shares up
May 7 (Reuters) – Insmed Inc can resume the development of its key drug Arikace after the U.S. health regulator lifted a second clinical hold on the drugmaker’s experimental treatment for lung disease, sending its shares up 47 percent.
Novartis lung drug meets goals in late-stage trials
ZURICH (Reuters) – A Novartis lung drug met its main goals in three late-stage studies in patients with chronic obstructive pulmonary disease (COPD), often known as smokers’ cough, the Swiss drugmaker said on Monday, giving its respiratory pipeline a boost.
FDA rejects Alimera eye drug again, seeks more trials
(Reuters) – U.S. health regulators declined to approve Alimera Sciences Inc’s experimental drug to treat retinal swelling for the second time citing safety issues, and asked the biopharmaceutical…